Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
0.569
-0.078 (-12.03%)
At close: Dec 20, 2024, 4:00 PM
0.544
-0.025 (-4.45%)
After-hours: Dec 20, 2024, 7:23 PM EST

Quoin Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Net Income
-8.7-8.69-9.38-21.46-2.1-1.56
Depreciation & Amortization
0.10.10.10.10.10.02
Other Amortization
---0.28--
Asset Writedown & Restructuring Costs
0.020.02----
Loss (Gain) From Sale of Investments
-0.31-0.49-0.09---
Stock-Based Compensation
1.231.090.76---
Other Operating Activities
--0.2214.730.38-
Change in Accounts Payable
-1.110.05-0.221.350.230.24
Change in Other Net Operating Assets
-0.080.040.12-0.720.05-
Operating Cash Flow
-8.84-7.86-8.48-5.72-1.34-1.3
Investment in Securities
3.932.19-9.9---
Other Investing Activities
---0.25-0.63-0.13-
Investing Cash Flow
3.932.19-10.15-0.63-0.13-
Short-Term Debt Issued
---3.481.981.3
Long-Term Debt Issued
---0.14--
Total Debt Issued
---3.611.981.3
Short-Term Debt Repaid
---0.31--0.05-
Long-Term Debt Repaid
--0.6-0.6-0.3--
Total Debt Repaid
-0.6-0.6-0.91-0.3-0.05-
Net Debt Issued (Repaid)
-0.6-0.6-0.913.311.931.3
Issuance of Common Stock
5.55.8514.8810.1--
Other Financing Activities
-0.03-0.030.040.09-0.14-
Financing Cash Flow
4.865.2214.0113.51.791.3
Net Cash Flow
-0.05-0.46-4.627.160.32-0
Free Cash Flow
-8.84-7.86-8.48-5.72-1.34-1.3
Free Cash Flow Per Share
-2.68-8.73-42.01-217.31-66.84-64.85
Cash Interest Paid
---0.39--
Levered Free Cash Flow
-5.64-4.68-6.21-7.63--
Unlevered Free Cash Flow
-5.64-4.68-5.77-7.06--
Change in Net Working Capital
1.140.020.853.37--
Source: S&P Capital IQ. Standard template. Financial Sources.